California-based Frontier Bio was named a Phase 1
Browsing: All news
Category Added in a WPeMatico Campaign
D&D Pharmatech reported publication in Lancet Gas
NeuroSense intends to proceed with a New Drug Sub
The Emerald update redesigns the app around acti
Federal court ruling highlights growing pressure
Federal court ruling highlights growing pressure
Wellthspan Advisory’s Nadine Esposito explains
New UAE-backed venture bets future of longevity
Cumulus Neuroscience and Muse bring lab-grade sl
As investment fuels brain diagnostics, Amprion’s expansion highlights growing belief that better tests are just as important as better drugs. The race against neurodegenerative disease has largely focused on finding the next breakthrough drug. However, a growing number of researchers…